Publications by authors named "Fu-Jen Lee"

Claim this Profile
A
A rural-to-center artificial intelligence model for diagnosing Helicobacter pylori infection and premalignant gastric conditions using endoscopy images captured in routine practice.
Tsung-Hsien Chiang, Yen-Ning Hsu, Min-Han Chen, Yi-Ru Chen, Hsiu-Chi Cheng, Fu-Jen Lee, Yi-Chia Lee

Endoscopy· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Value of Serum Mac-2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus-Infected Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
Yun-Chu Chen, Yu-Ping Chang, Ji-Yuh Lee, Chi-Yi Chen, Wei-Yu Kao, Fu-Jen Lee

J Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-response relationship of cadmium and pancreatic cancer risk: a meta-analysis.
Fu-Jen Lee, Hathaichon Inchai, Jaw-Town Lin, David Koh, Ro-Ting Lin

Occup Environ Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between metabolic dysfunction-associated steatotic liver disease, lean metabolic dysfunction-associated steatotic liver disease, and colorectal neoplasms: a cross-sectional study.
Kuan-Wei Wu, Kai-Shun Liang, Yao-Chun Hsu, Fu-Jen Lee, Chi-Yang Chang

Eur J Gastroenterol Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of glucagon-like peptide-1 receptor agonists on the quality indicators of colonoscopy - a systematic review and meta-analysis.
Yu-Tse Chiu, Yu-Tsung Chen, Fu-Jen Lee, Chi-Yang Chang

Dig Liver Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Prevalence of Barrett's Esophagus in Taiwan: A Prospective Multicenter Study.
Fu-Jen Lee, Ming-Chang Tsai, Chien-Lin Chen, Ming-Wun Wong, Hsu-Heng Yen

J Gastroenterol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral-Induced Cure of Hepatitis C Virus Infection.
Yu-Ping Chang, Ji-Yuh Lee, Chi-Yi Chen, Wei-Yu Kao, Chih-Lin Lin, Fu-Jen Lee

Aliment Pharmacol Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Serum Rheumatoid Factor Following Eradication of Hepatitis C Virus Infection With Interferon or Direct Antiviral Therapy.
Ying-Nan Tsai, Jamie Chieh Lo, Cheng-Hao Tseng, Song-Chou Hsieh, Wen-Chin Chiu, Fu-Jen Lee

J Viral Hepat· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seven-Day Vonoprazan-Based Triple Therapy as First-Line Helicobacter pylori Treatment in Comparison With Extended Sequential Therapy: A Randomized Controlled Trial.
Yu-Tse Chiu, Fu-Jen Lee, Chen-Ya Kuo, Yu-Tsung Chen, Yang-Chao Lin

Helicobacter· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antivirals.
Chen-Hua Liu, Yu-Ping Chang, Ji-Yuh Lee, Chi-Yi Chen, Wei-Yu Kao, Fu-Jen Lee

J Med Virol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan.
Chen-Hua Liu, Cheng-Yuan Peng, Chun-Jen Liu, Chi-Yi Chen, Ching-Chu Lo, Fu-Jen Lee, Pei-Lun Lee

Hepatol Int· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Dipeptidyl Peptidase-4 Inhibitors Use with Reduced Risk of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Chronic HBV Infection.
Tzu-I Chen, Fu-Jen Lee, Wan-Lun Hsu, Yong-Chen Chen, Mingchih Chen

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seven-day vonoprazan-based triple therapy as first-line treatment in comparison with extended sequential therapy.
Yu-Tse Chiu, Fu-Jen Lee, Chen-Ya Kuo, Yang-Chao Lin, Kai-Shun Liang

JGH Open· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dedicated staff for patient education improves bowel preparation quality and reduces the cecal intubation time of colonoscopy: A single institution retrospective study.
Yu-Tse Chiu, Chen-Ya Kuo, Fu-Jen Lee, Chi-Yang Chang

Medicine (Baltimore)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compositions of gut microbiota before and shortly after hepatitis C viral eradication by direct antiviral agents.
Yao-Chun Hsu, Chih-Cheng Chen, Wei-Hsiang Lee, Chi-Yang Chang, Fu-Jen Lee

Sci Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment.
Chen-Hua Liu, Chi-Yi Chen, Wei-Wen Su, Kuo-Chih Tseng, Ching-Chu Lo, Pei-Lun Lee, Fu-Jen Lee

Gut· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Dietary Intake Composition of Choline and Betaine Is Associated with Minimized Visceral Obesity-Related Hepatic Steatosis in a Case-Control Study.
Ting-Yu Chang, Chien-Hsien Wu, Chi-Yang Chang, Fu-Jen Lee, Bei-Wen Wang

Nutrients· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis.
Chen-Hua Liu, Chi-Yi Chen, Wei-Wen Su, Chun-Jen Liu, Ching-Chu Lo, Pei-Lun Lee, Fu-Jen Lee

Clin Mol Hepatol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan.
Chen-Hua Liu, Po-Yueh Chen, Jyh-Jou Chen, Ching-Chu Lo, Wei-Wen Su, Pei-Lun Lee, Fu-Jen Lee

Hepatol Int· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis